TECH

Bio-Techne
TECH

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$9.51B
EV
$9.79B
Shares Outstanding
155.69M
Beta
1.47
Industry
Biotechnology

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
Number of Analysts
12
P/E 2026E
30.55x
P/Revenue 2026E
7.68x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Bio-Techne Corporation

gainify
TECH

Bio-Techne Corporation

TECH

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, ...

Sector

Healthcare

Industry

Biotechnology

CEO

Kelderman, Kim

Employees

3,100

IPO Date

1989-02-09

Headquarters

614 McKinley Place N.E., Minneapolis, Minnesota, 55413, United States

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.